(Q33160123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

review article

1 reference

title

Assessing QT interval prolongation and its associated risks with antipsychotics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Jorgen K. Kanters

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

David Taylor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Jimmi Nielsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Egon Toft

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Jonathan M Meyer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

473-490

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21649448%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11587800-000000000-00000

3 February 2020

exact match

0 references

cites work

Drug-induced arrhythmias and sudden cardiac death: implications for the pharmaceutical industry

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

The negative autopsy: sudden cardiac death or other?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Cardiovascular risks of atypical antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

The genetic basis of long QT and short QT syndromes: a mutation update

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Drug- and non-drug-associated QT interval prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Calcium channel blockers, NOS1AP, and heart-rate-corrected QT prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Dispersions of repolarization and ventricular arrhythmogenesis: lessons from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Antipsychotic drugs and QT prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population: a review and qualitative overview of the prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

QT and TdP. QT: an unreliable predictor of proarrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Sudden cardiac death: epidemiology, mechanisms, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

The role of databases in drug postmarketing surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Atypical antipsychotic drugs and the risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Physical illness and schizophrenia: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Drug-induced long QT syndrome and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Excess mortality of schizophrenia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

QTc interval prolongation and antipsychotic drug treatments: focus on sertindole

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Antipsychotics and QT prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Thorough QT Studies: Questions and Quandaries

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

What Clinicians Should Know About the QT Interval

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Influence of food intake on electrocardiograms of healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Correction for QT/RR hysteresis in the assessment of drug-induced QTc changes--cardiac safety of gadobutrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Circadian rhythm of the corrected QT interval: impact of different heart rate correction models

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

The effect of sertindole on QTD and TPTE.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Sertindole causes distinct electrocardiographic T-wave morphology changes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Ziprasidone in the management of schizophrenia : the QT interval issue in context

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Cardiovascular effects of antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Measurement of the QT interval and the risk associated with QTc interval prolongation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Drug-induced prolongation of the QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Man versus machine: is there an optimal method for QT measurements in thorough QT studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

T(peak)T(end) interval in long QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Classification of the long-QT syndrome based on discriminant analysis of T-wave morphology.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

New descriptors of T-wave morphology are independent of heart rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Quantitative analysis of T-wave morphology increases confidence in drug-induced cardiac repolarization abnormalities: evidence from the investigational IKr inhibitor Lu 35-138.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Long QT syndrome genotyping by electrocardiography: fact, fiction, or something in between?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Antipsychotic-associated all-cause and cardiac mortality: what should we worry about and how should the risk be assessed?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

10-year trends in the treatment and outcomes of patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

The Sertindole Safety Survey: a retrospective analysis under a named patient use programme in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Comparative mortality associated with ziprasidone and olanzapine in real-world use among 18,154 patients with schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Psychiatrists' attitude towards and knowledge of clozapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Investigation of the potential of clozapine to cause torsade de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

21 January 2018

Last episode psychosis

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Cost-effectiveness of neonatal ECG screening for the long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Sudden cardiac death and antipsychotics Part 2: Monitoring and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11587800-000000000-00000

Mechanism of the cardiotoxic actions of terfenadine

21 January 2018

1 reference

12 December 2020

Beat-to-beat QT dynamics in healthy subjects

1 reference

12 December 2020

[Torsades de pointe. Apropos of 60 cases]

1 reference

12 December 2020

Clozapine-induced cardiotoxicity: a clinical update.

1 reference

12 December 2020

Ventricular tachycardia with 2 variable opposing foci

1 reference

12 December 2020

Electrocardiographic changes and serum concentrations in thioridazine-treated patients

1 reference

12 December 2020

Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions.

1 reference

12 December 2020

Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors

1 reference

12 December 2020

Drug-induced changes in the T-wave morphology

1 reference

12 December 2020

A case series of drug-induced long QT syndrome and Torsade de Pointes.

1 reference

12 December 2020

Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.

1 reference

12 December 2020

The European sertindole safety and exposure survey: a follow-up study of 8600 patients

1 reference

12 December 2020

Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion

1 reference

12 December 2020

Methods of assessment and clinical relevance of QT dynamics

1 reference

12 December 2020

Measurement error as a source of QT dispersion: a computerised analysis.

1 reference

12 December 2020

Clinical management of cardiovascular risks during treatment with psychotropic drugs.

1 reference

12 December 2020

The safety of atypical antipsychotics: does QTc provide all the answers?

1 reference

12 December 2020

The measurement of the Q-T interval of the electrocardiogram

1 reference

12 December 2020

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients

1 reference

12 December 2020

Phenothiazine-induced T-wave abnormalities. Effects of overnight fasting.

1 reference

12 December 2020

Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans

1 reference

12 December 2020

The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes

1 reference

12 December 2020

Subject-specific profiles of QT/RR hysteresis

1 reference

12 December 2020

QT interval: how to measure it and what is "normal"

1 reference

12 December 2020

Antipsychotic agents and sudden cardiac death--how should we manage the risk?

1 reference

12 December 2020

Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.

1 reference

12 December 2020

Mortality in a cohort of patients with schizophrenia: a record linkage study

1 reference

12 December 2020